Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-29

Clinical Trial Update: Anthrax Vaccine Clinical Trial to Assess Dose Reduction and Route Change [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating dose reduction and route changes for an anthrax vaccine in healthy participants; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anthrax vaccine (Anthrax vaccine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Healthy | Phase 4 | Status: COMPLETED | Results posted: 2024-05-29